异烟肼

yì yān jǐnɡ
  • isoniazide;Isoniazid
异烟肼异烟肼
  1. 方法:采用明胶和聚己内酯复合包裹法将异烟肼、利福平、吡嗪酰胺和乙胺丁醇等4种抗结核药物按一定浓度和配比与重组合异种骨(RBX)复合,制备抗结核骨。

    Method : Anti-TB bone was made of reconstituted bone xenograft ( RBX ) combined with 4 antituberculosis drugs ( Isoniazide , Rifampicin , Pyrazinamide , Ethambutol ) at certain concentration and encapsulated by gelatin and polycaprolactone .

  2. 铋膜玻碳电极阳极溶出伏安法测定异烟肼的研究

    Bismuth - coated glassy carbon electrodes for anodic stripping voltammetry determination of isoniazide

  3. DNA芯片联合检测耐利福平与异烟肼结核分枝杆菌及其临床应用

    Combined Detection of Rifampin-and Isoniazid-resistant Mycobacterium tuberculosis by DNA Chip and Its Clinical Application

  4. 还研究了异烟肼、对氨基柳酸以及两者合用时对维生素B6排泄的影响。

    The effects of INH , PAS and INH plus PAS on oxcretionof vitamin B_6 were also studied .

  5. HPLC法测定异福胶囊中异烟肼的溶出度

    Determination of Isoniazid in Dissolution Test for Yifu Capsules by HPLC

  6. HPLC法测定复方利福平气雾剂中利福平及异烟肼含量

    HPLC Determination of Rifampicin and Isoniazid in Compound Rifampicin Aerosol

  7. UV分光光度法测定复方异烟肼片中异烟肼的含量

    Determination of isoniazid in compound isoniazid tablets by UV spectrophotometry

  8. 泰国成年HIV感染者的异烟肼预防性治疗

    INH preventive therapy among adult HIV-infected patients in Thailand

  9. HPLC法测定异烟肼含量及有关物质

    HPLC determination of content and related substances of isoniazid

  10. 异烟肼的Fe(Ⅲ)-邻二氮菲分光光度测定

    Fe (ⅲ) - o-phenanthroline spectrophotometry of isoniazid

  11. 方法:采用HPLC定量分析法分别测定给药后受试者血浆中利福平、异烟肼及吡嗪酰胺三种有效成分浓度。

    METHOD : Rifampicin , Isoniazid and Pyrazinamide in plasma wad determined by HPLC .

  12. HPLC法检测结核性胸膜炎患者血清和胸液中异烟肼浓度

    Determination of isoniazid concentration of serum and hydrothorax of patients with tuberculous pleurisy by HPLC

  13. 差谱计算分光光度法测定复方异烟肼片中V(B6)的含量

    Determination of VB_6 in Compound Isoniazid Tablets by Differential Spectrum Computational Spectrophotometry

  14. 利福平吡嗪酰胺联用方案与异烟肼标准方案预防性治疗潜在结核感染效果的Meta分析

    Rifampicin Plus Pyrazinamide versus Isoniazid For Treating Latent Tuberculosis Infection : A Meta-analysis

  15. 采用等吸收双波长法测定复方异烟肼中异烟肼的含量,消除了维生素B6的干扰。本法简便、准确、重现性好。

    The isoniazid content was determined in compound isoniazid tablet using double wavelength spectrophotometry , which eliminated the interference of Vitamine B_6.It was simple , accurate and reproducible .

  16. RP-HPLC法测定异烟肼片中异烟肼含量

    Determination of Isoniazid in Isoniazid Tablets by RP-HPLC

  17. 靛红缩异烟肼Schiff碱配体L3。

    Schiff base ligand of N - isonicotinamidoisotin ( L3 ) .

  18. 1例异烟肼引起G6PD缺乏症患者急性溶血的护理

    Nursing of a Patient with G6PD Defiency Having Acute Hemolytic Syndrome Caused by Isoniazid

  19. 异烟肼可单独或与其他药物配合使用结核病(TB),或供结核病菌接触者预防用。

    Isoniazid is used alone or with other drugs to treat tuberculosis ( TB ) and to prevent it in people who have had contact with tuberculosis bacteria .

  20. 南平烟区烤烟氯化钾适宜用量的研究RP-HPLC法测定异烟肼片中异烟肼含量

    Effect of Potassium Chloride Application Rates on Yield and Quality of Flue-cured Tobacco in Nanping Area Determination of Isoniazid in Isoniazid Tablets by RP-HPLC

  21. 目的比较利福平吡嗪酰胺联用方案(RZ)与异烟肼方案(H)化学预防潜在结核感染的有效性和安全性。

    Objective To evaluate the efficacy and safety of rifampicin plus pyrazinamide versus isoniazid for prevention of tuberculosis among persons with or without HIV-infection respectively .

  22. 目的:研究利福平(rifampicin,LFP)和异烟肼(isoniazid,INH)对体外大鼠肝细胞的毒性。

    AIM : In vitro rat hepatocytes were used to study isoniazid and rifampicin induced hepatotoxicity .

  23. 测定了服异烟肼(INH)的肺结核病人121例,在服药前后血清中单胺氧化酶(MAO)的水平。

    Levels of serum monoamine oxidase were determined before and after treatment with isoniazid in 121 cases of pulmonary tuberculosis .

  24. 对采用优化处方制备的三批样品进行了质量评价和初步稳定性实验,还采用不同的模型研究了异烟肼缓释胶囊的释药机理,该缓释胶囊符合FDA释放限度要求。

    The different models were used to study the releasing mechanism of isoniazid sustained-release capsules , which accorded with criterion of assay and FDA release limit .

  25. 应用短萼海桐提取液的含药血清及MΦ的TB感染模型评价短萼海桐的抗结核杆菌活性,设阳性(异烟肼)及阴性(空白、血清)对照组;

    Firstly , the activity of PB of anti-mycobacterium tuberculosis was valued by using the containing medicine serum and infected macrophages model , and positive and negative contrasts were set up .

  26. 耐多药结核病(MDR-TB)指的是致病结核菌至少同时耐异烟肼(INH)和利福平(RFP)。

    Multi-drug resistant tuberculosis ( MDR-TB ) refers to tuberculous mycobacteria resist to at least isoniazid and rifampicin .

  27. 目的:应用胶束动电毛细管电泳(MECC)技术分离测定卫非宁片中的异烟肼和利福平。

    Objective : To determine rifampicin and isoniazid in Rifinah tablets by using of MECC technique .

  28. 目的:耐多药结核病(MDR-TB)是指至少对抗结核药物中异烟肼(INH)、利福平(RFP)产生耐药的结核病。

    Objective : Multidrug resistant tuberculosis ( MDR-TB ) is defined as resistance to at least the first-line drugs isoniazid and rifampin .

  29. 世界卫生组织推荐艾滋病感染者/患者使用抗结核药异烟肼(isoniazid)减少潜伏结核病被激活的可能性。

    The World Health Organization recommends that HIV / AIDS patients take the antibiotic isoniazid to reduce the chance of latent TB becoming active .

  30. 结核病例的发现未得到充分改善,对异烟肼的抗药性的担忧制约着国家IPT政策方面的制定和执行。

    Inadequate intensified tuberculosis case-finding and concerns regarding isoniazid resistance were challenges to the development and implementation of national IPT policies .